{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T22:26:53Z","timestamp":1747780013836},"publisher-location":"Berlin, Heidelberg","reference-count":43,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642849589"},{"type":"electronic","value":"9783642849565"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-3-642-84956-5_3","type":"book-chapter","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T21:58:21Z","timestamp":1325800701000},"page":"45-55","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Sandostatin on Neuroendocrine Tumours of the Gastrointestinal System"],"prefix":"10.1007","author":[{"given":"K. D.","family":"Buchanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"119","key":"3_CR1","first-page":"115","volume":"21","author":"J Anderson","year":"1986","unstructured":"Anderson J, Bloom SR (1986) Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201\u2013995.Scand J Gastroenterol 21 [Suppl 119]: 115\u2013128","journal-title":"Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995.Scand J Gastroenterol"},{"issue":"6","key":"3_CR2","first-page":"989","volume":"100","author":"AF Altimari","year":"1986","unstructured":"Altimari AF, Bhoopalam N, O\u2019Dorisio T, Lange CL, Sandberg L, Prinzi RA (1986) Use of a somatostatin analog (SMS 201\u2013995) in the glucagonoma syndrome. Surgery 100 (6): 989\u2013996","journal-title":"Surgery"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/archderm.1989.01670150084014","volume":"125","author":"AR Altman","year":"1989","unstructured":"Altman AR, Tschen JA, Rice L (1989) Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue. Arch Dermatol 125: 394\u2013396","journal-title":"Arch Dermatol"},{"issue":"3","key":"3_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00004836-198906000-00007","volume":"11","author":"FE Bauer","year":"1989","unstructured":"Bauer FE, Hummel M, Merki HS, Schulz E, Oeder R, Marbach P (1989) Long-acting somatostatin analog controls acid and gastrin secretion in benign, but in malignant, Zollinger-Ellison syndrome. J Clin Gastroenterol 11 (3): 282\u2013286","journal-title":"J Clin Gastroenterol"},{"issue":"26","key":"3_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM198606263142606","volume":"314","author":"G Boden","year":"1986","unstructured":"Boden G, Ryan IG, Eisenschmid BL, Shelmet JJ, Owen OE (1986) Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201\u2013995. N Engl J Med 314 (26): 1686\u20131689","journal-title":"N Engl J Med"},{"key":"3_CR6","unstructured":"Bonfils S, Ruszniewski P, Laucournet H, Costil V, Rene W, Mignon M (1986) Long-term management of Zollinger-Ellison syndrome with SMS 201\u2013995, a long-lasting somatostatin analog. Program of the 6th International Symposium on Gastrointestinal Hormones, Vancouver, Canada, July 6\u201310, 1986. Can J Physiol Pharmacol, p 63"},{"key":"3_CR7","first-page":"117","volume":"1191","author":"G Brabant","year":"1986","unstructured":"Brabant G, Muller MJ, Rotsch M et al (1986) Treatment of carcinoid syndrome and VIPoma with a long-acting somatostatin analogue (SMS 201\u2013995). Scan J Gastroenterol 21 [Suppl 1191: 117\u2013180","journal-title":"Scan J Gastroenterol 21 [Suppl"},{"issue":"4","key":"3_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00000441-199010000-00011","volume":"300","author":"NJ Brown","year":"1990","unstructured":"Brown NJ (1990) Octreotide: a long-acting somatostatin analog. Am J Med Sci 300 (4): 267\u2013273","journal-title":"Am J Med Sci"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00365528609087453","volume":"1191","author":"KD Buchanan","year":"1986","unstructured":"Buchanan KD, Shaw C, O\u2019Hare MMT, Dalzell G (1986 a) Evaluation of SMS 201\u2013995 in gastrointestinal APUDomas. Scand J Gastroenterol 21 [Suppl 1191: 199\u2013205","journal-title":"Scand J Gastroenterol 21 [Suppl"},{"key":"3_CR10","doi-asserted-by":"crossref","unstructured":"Buchanan KD, Johnston CF, O\u2019Hare MMT, Ardill JES, Shaw C, Collins JSA, Watson RGP, Atkinson AB, Hadden DR, Kennedy TL, Sloan JM (1986 b) Neuroendocrine tumours \u2014 a european view. Am J Med 81 [Suppl 6B]:14\u201322","DOI":"10.1016\/0002-9343(86)90581-4"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000200255","volume":"11","author":"KD Buchanan","year":"1990","unstructured":"Buchanan KD, Collins JSA, Varghese A, Johnston CF, Shaw C (1990a) Sandostatin and the Belfast experience. Digestion 45 [Suppl 11: 11\u201316","journal-title":"Digestion 45 [Suppl"},{"issue":"282","key":"3_CR12","first-page":"1091","volume":"77","author":"KD Buchanan","year":"1990","unstructured":"Buchanan KD, Shaw C, McGrath SJ, McKillop JM, Harrison E, Johnston CF, McGuigan J, Gibbons JRP (1990 b) Regulatory peptide content of lung and mid-gut carcinoid tumours. Q J Med 77 (282): 1091","journal-title":"Q J Med"},{"issue":"12","key":"3_CR13","first-page":"511","volume":"89","author":"PSG Cervigon","year":"1987","unstructured":"Cervigon PSG, Navarro JIF, de Diego JS, Asensi AC, Hernandez FC, Jara Albarran A (1987) Tratamiento preoperatorio de la hipoglucemia debida a un insulinoma con el analogo de somatostatina SMS 201\u2013995.Med Clin (Bare) 89 (12): 511\u2013513","journal-title":"Tratamiento preoperatorio de la hipoglucemia debida a un insulinoma con el analogo de somatostatina SMS 201-995.Med Clin (Bare)"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0002-9343(85)90559-5","volume":"79","author":"JLC Ch\u2019ng","year":"1985","unstructured":"Ch\u2019ng JLC, Christofides ND, Kraenzlin ME, Keshavarzian A, Burrin JM, Woolf IL, Hodgson HJF, Bloom SR (1985) Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production. Am J Med 79: 135\u2013138","journal-title":"Am J Med"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/bmj.292.6526.981","volume":"292","author":"JLC Ch\u2019ng","year":"1986","unstructured":"Ch\u2019ng JLC, Anderson JV, Williams SJ, Carr DH, Bloom SR (1986) Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue. Br Med J 292: 981\u2013982","journal-title":"Br Med J"},{"issue":"287","key":"3_CR16","first-page":"215","volume":"78","author":"JSA Collins","year":"1991","unstructured":"Collins JSA, Buchanan KD, Kennedy TL, Johnston CF, Ardill JES, Sloan JM, Mcllrath EM, Russel C (1991) Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970\u20131988. Q J Med (New Series) 78 (287): 215\u2013225","journal-title":"Q J Med (New Series)"},{"issue":"2","key":"3_CR17","first-page":"437","volume":"100","author":"EC Ellison","year":"1986","unstructured":"Ellison EC, O\u2019Dorisio TM, Sparks J, Mekhjian HS, Fromkes JJ, Woltering EA, Carey LC (1986) Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of APUDomas. Surgery 100 (2): 437","journal-title":"Surgery"},{"issue":"6","key":"3_CR18","first-page":"962","volume":"100","author":"GW Geelhoed","year":"1986","unstructured":"Geelhoed GW, Bass BL, Mertz SL, Becker KL (1986) Somatostatin analog: effects on hypergastrinemia and hypercalcitoninemia. Surgery 100 (6): 962\u2013970","journal-title":"Surgery"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000181005","volume":"29","author":"PR Hearn","year":"1988","unstructured":"Hearn PR, Ahmed M, Woodhouse NJY (1988) The use of SMS 201\u2013995 (somatostatin analogue) in insulinomas. Hormone Res 29: 211\u2013213","journal-title":"Hormone Res"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(89)91258-0","volume":"1","author":"EP Krenning","year":"1989","unstructured":"Krenning EP, Breeman WAP, Kooij PPM, Lamberts JS, Bakker WH, Koper JW, Ausema L, Reubi JC, Lamberts SWJ (1989) Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1: 242\u2013244","journal-title":"Lancet"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2265.1987.tb01175.x","volume":"27","author":"AWC Kung","year":"1987","unstructured":"Kung AWC, Ma JTC, Wang C, Fu KH, Lam KSL, Yeung RTT, Boey J (1987) Prevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201\u2013995. Clin Endocrinol 27: 469\u2013473","journal-title":"Clin Endocrinol"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-107-2-162","volume":"107","author":"LK Kvols","year":"1987","unstructured":"Kvols LK, Buck M, Moertel CG, Schutt AJ, Rubin J, O\u2019Connell MJ, Hahn RG (1987) Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201995). Ann Intern Med 107: 162\u2013168","journal-title":"Ann Intern Med"},{"key":"3_CR23","doi-asserted-by":"crossref","unstructured":"Lamberts SWJ, Bakker WH, Reubi J-C, Krenning EP (1990) Clinical application of somatostatin analogs. Part I. Metabolism 39 (9) [Suppl 2]: 152\u2013155","DOI":"10.1016\/1043-2760(90)90025-X"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00000542-198701000-00021","volume":"66","author":"HM Marsh","year":"1987","unstructured":"Marsh HM, Martin JK, Kvols LK et al (1987) Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology 66: 89\u201391","journal-title":"Anesthesiology"},{"issue":"119","key":"3_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/00365528609087449","volume":"21","author":"PN Maton","year":"1986","unstructured":"Maton PN, O\u2019Dorisio TM, O\u2019Dorisio MS, Malarkey WB, Gower WJ Jr, Gardner JD, Jensen RT (1986) Successful therapy of pancreatic cholera with the long-acting somatostatin analogue SMS 201\u2013995. Relation between plasma concentrations of drug and clinical and biochemical responses. Scand J Gastroenterol 21 [Suppl 119]: 181\u2013186","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"3_CR26","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.1007\/BF01536043","volume":"34","author":"PN Maton","year":"1989","unstructured":"Maton PN, Gardner JD, Jensen RT (1989) Use of long-acting somatostatin analog SMS 201\u2013995 in patients with pancreatic islet cell tumors. Dig Dis Sci 34 (3): 28S - 39S","journal-title":"Dig Dis Sci"},{"key":"3_CR27","first-page":"476","volume":"170","author":"E Mozell","year":"1990","unstructured":"Mozell E, Woltering EA, O\u2019Dorisio TM, Fletcher WS, Sinclair AJ, Hill D (1990) Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome. Surg Gynecol Obstet 170: 476\u2013484","journal-title":"Surg Gynecol Obstet"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1210\/jcem-63-3-605","volume":"63","author":"I Norheim","year":"1986","unstructured":"Norheim I, Theodorsson-Norheim E, Brodin E, Oberg K (1986) Tachykinins in carcinoid tumors; their use as a tumor marker and possible role in the carcinoid flush. J Clin Endocrinol Metab 63: 605","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"3_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0960-0760(92)90184-K","volume":"43","author":"JC Reubi","year":"1992","unstructured":"Reubi JC, Laissue J, Krenning E, Lamberts SWJ (1992) Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 43 (1\u20133): 27\u201335","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/BF01295657","volume":"27","author":"A Ruskone","year":"1982","unstructured":"Ruskone A, Rene E, Chayvialle JA, Bonin N, Pignal F, Kremer M, Bonfils S, Rambaud JC (1982) Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci 27: 459\u2013466","journal-title":"Dig Dis Sci"},{"key":"3_CR31","first-page":"86","volume":"35","author":"CDA Stehouwer","year":"1989","unstructured":"Stehouwer CDA, Lems WF, Fischer HRA, Hackeng WHL (1989) Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201\u2013995) more effective than single therapy with either drug? Neth J Med 35: 86\u201394","journal-title":"Neth J Med"},{"key":"3_CR32","first-page":"199","volume":"38","author":"R Timmer","year":"1991","unstructured":"Timmer R, Koningsberger JC, Erkelens DW, Thijssen JHH, Lips CJM, Koppeschaar HPF (1991) No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma. Neth J Med 38: 199\u2013203","journal-title":"Neth J Med"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/0002-9343(58)90075-5","volume":"25","author":"JV Verner","year":"1958","unstructured":"Verner JV, Morrison AB (1958) Islet cell tumour and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 25: 374\u2013380","journal-title":"Am J Med"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.1986.tb03609.x","volume":"25","author":"L Verschoor","year":"1986","unstructured":"Verschoor L, Uitterlinden P, Lamberts SWJ, del Pozo E (1986) On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma. Clin Endocrinol 25: 555 \u2014 560","journal-title":"Clin Endocrinol"},{"issue":"3","key":"3_CR35","doi-asserted-by":"publisher","first-page":"14S","DOI":"10.1007\/BF01536042","volume":"34","author":"A Vinik","year":"1989","unstructured":"Vinik A, Moattari AR (1989) Use of somatostatin analog in management of carcinoid syndrome. Dig Dis Sci 34 (3): 14S - 27S","journal-title":"Dig Dis Sci"},{"key":"3_CR36","doi-asserted-by":"crossref","unstructured":"Von Werder K, Losa M, Muller OA, Schweiberer L, Fahlbusch R, del Pozo E (1984) Treatment of metastasizing GRF-producing tumor with a long-acting somatostatin analogue. Lancet ii: 282 \u2014 283","DOI":"10.1016\/S0140-6736(84)90320-9"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/00365528609087460","volume":"1191","author":"K Werder Von","year":"1986","unstructured":"Von Werder K, Losa M, Stalla GK, Muller OA, Mayr B, Schweiberer L, Fahlbusch LR (1986) Long-term treatment of a metastasizing GRFoma with a somatostatin analogue (SMS 201\u2013995) in a girl with gigantism. Scand J Gastroenterol 21 [Suppl 1191: 238\u2013242","journal-title":"Scand J Gastroenterol 21 [Suppl"},{"issue":"267","key":"3_CR38","first-page":"647","volume":"72","author":"RGP Watson","year":"1989","unstructured":"Watson RGP, Johnston CF, O\u2019Hare MMT, Anderson JR, Wilson BG, Coillins JSA, Sloan JM, Buchanan KD (1989) The frequency of gastrointestinal endocrine tumours in a well-defined population \u2014 Northern Ireland 1970\u20131985. Quart J Med (New Series) 72 (267): 647\u2013657","journal-title":"Quart J Med (New Series)"},{"key":"3_CR39","volume-title":"Sandostatin in the treatment of gastroenteropancreatic endocrine tumors","author":"G Williams","year":"1987","unstructured":"Williams G, Bloom SR (1987) Long-term treatment of VIPoma and glucagonoma with Sandostatin. In: O\u2019Dorisio TM (ed) Sandostatin in the treatment of gastroenteropancreatic endocrine tumors. Springer, Berlin Heidelberg New York"},{"issue":"1985","key":"3_CR40","first-page":"39","volume":"1921","author":"DM Wilson","year":"1985","unstructured":"Wilson DM, Hoffman AR (1985) Reduction of pituitary size in a patient with a GRF secreting islet cell tumor by continuous infusion of a somatostatin analogue. Program of the Endocrine Society 6th Annual Meeting, Baltimore, Maryland, June 19\u201321, 1985, p 39","journal-title":"June"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/acta.0.1130023","volume":"113","author":"DM Wilson","year":"1986","unstructured":"Wilson DM, Hoffman AR (1986) Reduction of pituitary size by the somatostatin analogue SMS 201\u2013995 in a patient with an islet cell tumour secreting growth hormone releasing factor. Acta Endocrinol 113: 23\u201328","journal-title":"Acta Endocrinol"},{"key":"3_CR42","first-page":"17","volume":"11","author":"HF Woods","year":"1990","unstructured":"Woods HF, Bax NDS, Ainsworth I (1990) Abdominal carcinoid tumours in Sheffield. Dig 45 [Suppl 11: 17\u201322","journal-title":"Dig 45 [Suppl"},{"issue":"1","key":"3_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jcem-73-1-1","volume":"73","author":"D Wynick","year":"1991","unstructured":"Wynick D, Bloom SR (1991) The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumours. J Clin Endocrinol Metab 73 (1): 1\u20133","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Recent Results in Cancer Research","Peptides in Oncology II"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-84956-5_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T15:45:35Z","timestamp":1620315935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-84956-5_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9783642849589","9783642849565"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-84956-5_3","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1993]]}}}